SCHEMBL13744457

SCHEMBL13744457

CN(C)[C@H]1CC[C@H](C(=O)Nc2c(C(=O)Nc3ccc(Cl)cn3)oc3cc(Br)ccc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 4/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ SORT1 Q99523 1/20 0.44
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ GSK3B P49841 3/20 0.41
▸ DYRK1A Q13627 3/20 0.41
▸ WNT1 P04628 2/20 0.41
▸ HSD17B10 Q99714 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ DHODH Q02127 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2943360 0.92 DEGS1 (0.47) F10SMN1; SMN2MEN1KMT2AGSK3B
SCHEMBL2943361 0.92 DEGS1 (0.47) F10SMN1; SMN2MEN1KMT2AGSK3B
Hydrochloric Acid SCHEMBL2942118 0.91 DEGS1 (0.46) F10SMN1; SMN2MEN1KMT2AGSK3B
SCHEMBL13744459 0.91 SMN1; SMN2 (0.47) F10SMN1; SMN2MEN1KMT2AGSK3B
Hydrochloric Acid SCHEMBL2942122 0.91 DEGS1 (0.46) F10SMN1; SMN2MEN1KMT2AGSK3B
SCHEMBL2940027 0.89 HSD17B10 (0.50) F10SMN1; SMN2MEN1KMT2AGSK3B
SCHEMBL2940021 0.89 HSD17B10 (0.50) F10SMN1; SMN2MEN1KMT2AGSK3B
SCHEMBL2940128 0.88 SMN1; SMN2 (0.59) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
SCHEMBL2940131 0.88 SMN1; SMN2 (0.59) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
Hydrochloric Acid SCHEMBL2947078 0.87 SMN1; SMN2 (0.58) SMN1; SMN2MEN1KMT2AHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 F10 5/4885SMN1; SMN2 3067/4885SORT1 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback